Project Grant HT94252310327
Award Date
5/1/23
Completion Date
4/30/27
Dollars Obligated
$8.4M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
The Regents of the University of Michigan received a $312,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The 2-year grant, awarded on February 1, 2024, supports research to investigate "An Unexpected Role for the Ubiquitin Proteasome System in Repeat Associated Non-AUG Translation." This basic and translational biomedical research aims to advance understanding and treatment of neurological disorders...
The University of Michigan will receive $304,472 over two years through a Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research into regulating prostate skeletal bone metastases through TIM-3-dependent efferocytosis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through innovative and...
The University of Michigan was awarded a $2,473,957 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program. The grant will support research from June 2021 through June 2025 on the Physiologic Signaling and Exoskeleton Control of the Muscle Cuff Regenerative Peripheral Nerve Interface during Volitional Behavior. Through this funding, the University of Michigan will investigate medical solutions for the battlefield by...
The Department of Defense's Defense Health Agency awarded a $1,500,000 Project Grant to the Regents of the University of Michigan to develop "Regenerative Peripheral Nerve Interfaces to Enhance Function and Sensation in People with Transfemoral Amputation" over 4 years, from September 1, 2023 to August 31, 2027. This grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform healthcare for Service Members...
The Defense Health Agency awarded a $1,178,939.00 Project Grant to the Regents of the University of Michigan under the Military Medical Research and Development program (CFDA 12.420) to conduct advanced phenotyping research to improve diagnostic, longitudinal assessment, and treatment strategies for deployment-related respiratory disease. The award period is from September 1, 2023 to August 31, 2026. As a U.S. Government Entity and top public research university, the University of Michigan has...
This federal Project Grant award of $1,206,372.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at the University of Michigan to investigate the role of primary cilia alterations in the pathogenesis and treatment of systemic sclerosis. The 4-year award, running from April 15, 2025 to April 14, 2029, will enable researchers to conduct advanced biomedical research into innovative approaches for diagnosing, preventing, and...
This $1,100,747 federal Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research initiatives at the University of Michigan. The grant will fund the development of innovative antibody-drug conjugates that coordinate the innate and adaptive immune systems to generate curative responses. Over a three-year period from April 1, 2025 to March 31, 2028, the research aims to transform healthcare...
This $1,404,000.00 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to the Regents of the University of Michigan, Office of Research and Sponsored Projects (doing business as the University of Michigan) on September 1, 2023. The funding will support research to target the lipid kinase PIKfyve in neuroendocrine prostate cancer over a 3-year period ending on August 31, 2026. The University of Michigan is a leading U.S....
This Project Grant award of $731,980.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Regents of the University of Michigan. The award will fund a research project titled "A DATA-DRIVEN APPROACH TO INDIVIDUALIZED CONCUSSION RISK PREDICTION IN U.S. SERVICE ACADEMY CADETS AND MIDSHIPMEN" from August 1, 2024 to July 31, 2027. The project aims to develop an individualized concussion risk prediction model for...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $360,116.00 to the Regents of the University of Michigan to conduct research on "BRIEF PAIN REPROCESSING THERAPY: AN OPTIMIZED INTEGRATIVE EXPOSURE INTERVENTION FOR VETERANS WITH CHRONIC LOW BACK PAIN." The research project aims to develop and evaluate an innovative therapy to address chronic low back pain among veterans. The award has a...